Britto-Júnior José, Ribeiro André, Ximenes Luiz, Lima Antonio Tiago, Jacintho Felipe Fernandes, Fregonesi Adriano, Mónica Fabíola Z, Antunes Edson, De Nucci Gilberto
Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, SP, Brazil.
Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, SP, Brazil.
Eur J Pharmacol. 2022 Jan 15;915:174716. doi: 10.1016/j.ejphar.2021.174716. Epub 2021 Dec 22.
6-nitrodopamine (6-ND) is released from rat isolated vas deferens and modulates electrical-field stimulation (EFS) contractions of the rat isolated epididymal vas deferens (RIEVD) via a specific receptor which is blocked by tricyclic antidepressants. Here, the effects of selective α-adrenergic receptor antagonists on RIEVD contractions induced by 6-ND, dopamine, noradrenaline, adrenaline and EFS were investigated. Doxazosin and tamsulosin (3-10 nM) caused significant rightward shifts of the concentration-response curve to 6-ND, but had no effect on dopamine-, noradrenaline- and adrenaline-induced contractions. Alfuzosin (10 nM) produced rightward shifts on concentration-response curves to all catecholamines. Silodosin (10 nM) and terazosin (100 nM) displaced to the right the noradrenaline, dopamine and adrenaline curves, but higher concentrations of both antagonists (100 and 300 nM, respectively) were required to displace the 6-ND curves. The EFS-induced contractions were significantly inhibited only at the concentrations that the α-adrenergic receptor antagonists caused rightward shifts on the 6-ND concentration-response curves. The inhibition of EFS-induced contractions by doxazosin (10 nM), tamsulosin (10 nM), alfuzosin (10 nM), silodosin (100 nM) and terazosin (300 nM), were not observed in RIEVD obtained from animals chronically treated with L-NAME. This work demonstrates that α-adrenoceptor antagonists act as 6-ND receptor antagonists in RIEVD, opening the possibility that many actions previously attributed to noradrenaline could be due to 6-ND antagonism. In addition, blockade of the 6-ND receptors by both tricyclic antidepressants and α-adrenergic receptor antagonists may represent the common mechanism of action responsible for their therapeutic use in the treatment of premature ejaculation.
6-硝基多巴胺(6-ND)从大鼠离体输精管释放,并通过一种特定受体调节大鼠离体附睾输精管(RIEVD)的电场刺激(EFS)收缩,该受体可被三环类抗抑郁药阻断。在此,研究了选择性α-肾上腺素能受体拮抗剂对由6-ND、多巴胺、去甲肾上腺素、肾上腺素和EFS诱导的RIEVD收缩的影响。多沙唑嗪和坦索罗辛(3-10 nM)使6-ND的浓度-反应曲线显著右移,但对多巴胺、去甲肾上腺素和肾上腺素诱导的收缩无影响。阿夫唑嗪(10 nM)使所有儿茶酚胺的浓度-反应曲线右移。西洛多辛(10 nM)和特拉唑嗪(100 nM)使去甲肾上腺素、多巴胺和肾上腺素曲线右移,但需要更高浓度的两种拮抗剂(分别为100和300 nM)才能使6-ND曲线右移。仅在α-肾上腺素能受体拮抗剂使6-ND浓度-反应曲线右移的浓度下,EFS诱导的收缩才受到显著抑制。在从长期用L-NAME处理的动物获得的RIEVD中,未观察到多沙唑嗪(10 nM)、坦索罗辛(10 nM)、阿夫唑嗪(10 nM)、西洛多辛(100 nM)和特拉唑嗪(300 nM)对EFS诱导收缩的抑制作用。这项工作表明,α-肾上腺素能受体拮抗剂在RIEVD中作为6-ND受体拮抗剂起作用,这表明许多先前归因于去甲肾上腺素的作用可能是由于6-ND拮抗作用。此外,三环类抗抑郁药和α-肾上腺素能受体拮抗剂对6-ND受体的阻断可能代表了它们在治疗早泄中治疗用途的共同作用机制。